Literature DB >> 21732785

Mitochondrial disorders of DNA polymerase γ dysfunction: from anatomic to molecular pathology diagnosis.

Linsheng Zhang1, Sherine S L Chan, Daynna J Wolff.   

Abstract

CONTEXT: Primary mitochondrial dysfunction is one of the most common causes of inherited disorders predominantly involving the neuromuscular system. Advances in the molecular study of mitochondrial DNA have changed our vision and our approach to primary mitochondrial disorders. Many of the mitochondrial disorders are caused by mutations in nuclear genes and are inherited in an autosomal recessive pattern. Among the autosomal inherited mitochondrial disorders, those related to DNA polymerase γ dysfunction are the most common and the best studied. Understanding the molecular mechanisms and being familiar with the recent advances in laboratory diagnosis of this group of mitochondrial disorders are essential for pathologists to interpret abnormal histopathology and laboratory results and to suggest further studies for a definitive diagnosis.
OBJECTIVES: To help pathologists better understand the common clinical syndromes originating from mutations in DNA polymerase γ and its associated proteins and use the stepwise approach of clinical, laboratory, and pathologic diagnosis of these syndromes. DATA SOURCES: Review of pertinent published literature and relevant Internet databases.
CONCLUSIONS: Mitochondrial disorders are now better recognized with the development of molecular tests for clinical diagnosis. A cooperative effort among primary physicians, diagnostic pathologists, geneticists, and molecular biologists with expertise in mitochondrial disorders is required to reach a definitive diagnosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21732785      PMCID: PMC3158670          DOI: 10.5858/2010-0356-RAR.1

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  94 in total

1.  Progessive cerebral degeneration of infancy.

Authors:  B J ALPERS
Journal:  J Nerv Ment Dis       Date:  1960-06       Impact factor: 2.254

2.  Disease mutations in the human mitochondrial DNA polymerase thumb subdomain impart severe defects in mitochondrial DNA replication.

Authors:  Rajesh Kasiviswanathan; Matthew J Longley; Sherine S L Chan; William C Copeland
Journal:  J Biol Chem       Date:  2009-05-28       Impact factor: 5.157

3.  The hydrogen hypothesis for the first eukaryote.

Authors:  W Martin; M Müller
Journal:  Nature       Date:  1998-03-05       Impact factor: 49.962

4.  Evidence for a direct role of the DNA polymerase gamma in the replication of the human mitochondrial DNA in vitro.

Authors:  P Lestienne
Journal:  Biochem Biophys Res Commun       Date:  1987-08-14       Impact factor: 3.575

5.  Brain MRI and proton MRS findings in infants and children with respiratory chain defects.

Authors:  A Dinopoulos; K M Cecil; M B Schapiro; A Papadimitriou; G M Hadjigeorgiou; B Wong; T deGrauw; J C Egelhoff
Journal:  Neuropediatrics       Date:  2005-10       Impact factor: 1.947

6.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

7.  The common A467T mutation in the human mitochondrial DNA polymerase (POLG) compromises catalytic efficiency and interaction with the accessory subunit.

Authors:  Sherine S L Chan; Matthew J Longley; William C Copeland
Journal:  J Biol Chem       Date:  2005-07-16       Impact factor: 5.157

8.  Structural insight into processive human mitochondrial DNA synthesis and disease-related polymerase mutations.

Authors:  Young-Sam Lee; W Dexter Kennedy; Y Whitney Yin
Journal:  Cell       Date:  2009-10-16       Impact factor: 41.582

9.  Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease.

Authors:  Fernando Scaglia; Jeffrey A Towbin; William J Craigen; John W Belmont; E O'Brian Smith; Stephen R Neish; Stephanie M Ware; Jill V Hunter; Susan D Fernbach; Georgirene D Vladutiu; Lee-Jun C Wong; Hannes Vogel
Journal:  Pediatrics       Date:  2004-10       Impact factor: 7.124

Review 10.  The in-depth evaluation of suspected mitochondrial disease.

Authors:  Richard H Haas; Sumit Parikh; Marni J Falk; Russell P Saneto; Nicole I Wolf; Niklas Darin; Lee-Jun Wong; Bruce H Cohen; Robert K Naviaux
Journal:  Mol Genet Metab       Date:  2008-02-01       Impact factor: 4.797

View more
  7 in total

1.  Rare variant of unknown significance in POLG1 and diagnostic dilemma.

Authors:  Pankaj Prasun
Journal:  J Neurol       Date:  2014-09-11       Impact factor: 4.849

Review 2.  Inherited mitochondrial genomic instability and chemical exposures.

Authors:  Sherine S L Chan
Journal:  Toxicology       Date:  2017-07-26       Impact factor: 4.221

3.  Small Circular DNAs in Human Pathology.

Authors:  Stephany Carolina Barreto; Madhuri Uppalapati; Amitabha Ray
Journal:  Malays J Med Sci       Date:  2014-05

4.  Telbivudine and adefovir dipivoxil combination therapy improves renal function in patients with chronic hepatitis B: A STROBE-compliant article.

Authors:  Yong Xu; Zhen-Wang Nie
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

5.  Progressive External Ophthalmoplegia in Polish Patients-From Clinical Evaluation to Genetic Confirmation.

Authors:  Biruta Kierdaszuk; Magdalena Kaliszewska; Joanna Rusecka; Joanna Kosińska; Ewa Bartnik; Katarzyna Tońska; Anna M Kamińska; Anna Kostera-Pruszczyk
Journal:  Genes (Basel)       Date:  2020-12-31       Impact factor: 4.096

6.  Fidelity of a Bacterial DNA Polymerase in Microgravity, a Model for Human Health in Space.

Authors:  Aaron H Rosenstein; Virginia K Walker
Journal:  Front Cell Dev Biol       Date:  2021-11-29

7.  Mitochondrial-associated metabolic disorders: foundations, pathologies and recent progress.

Authors:  Joseph McInnes
Journal:  Nutr Metab (Lond)       Date:  2013-10-12       Impact factor: 4.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.